maytansinoid based antibody-drug conjugate

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namemaytansinoid based antibody-drug conjugate
Drug Alias NameM-PI-(LDL)-DM folate receptor alpha modulator (ImmunoGen)M-PI-(LDL)-DM
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionFolate receptor alpha modulators
TargetsFolate receptor alpha
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesImmunogen Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesImmunogen Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A